Bioequivalence Evaluation of a New and Current Tablet of ASP015K
NCT02531191
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
peficitinib
Sponsor
Astellas Pharma Inc